0
×

Selected Tests

No tests selected yet.

آپکی صحت کا نمبر 24/7

03-111-456-789

Immunoglobulins (IgA,IgG,IgM)

Specimen Required

3-5cc Clotted Blood or Serum

Fasting Required

Add To Cart

Purpose of the Test

To help evaluate a person’s immune system status; to detect and monitor an excess or deficiency in one or more of the immunoglobulin classes (IgG, IgA, and IgM)

When this test is required

This test is requested when a person has symptoms of an immunoglobulin deficiency such as recurrent infections, especially of the respiratory tract (sinus, lungs) or gastrointestinal tract (stomach, intestines), and/or chronic diarrhoea. It may be part of the investigation of anaeamia, raised white cell count, bone pain or fractures that occur with minimal trauma (pathological fractures).Immunoglobulins testing may also be requested when a person has signs of chronic inflammation or chronic infection and when a healthcare professional suspects excess or abnormal immunoglobulin production. The test may be requested periodically to monitor the course of a person’s condition.This test may also be performed on cerebrospinal fluid (CSF) whenever a healthcare professional suspects that a condition affecting the central nervous system (CNS) may be associated with excess immunoglobulin production.

What the Test Detects

Immunoglobulins play a key role in the body’s immune system. They are proteins produced by specific immune cells called plasma cells in response to bacteria, viruses, and other microorganisms as well as exposures to other substances that are recognised by the body as “non-self” harmful antigens. This test measures the amount of immunoglobulins A, G, and M (IgA, IgG, IgM) in the blood and, in certain circumstances, in cerebrospinal…Immunoglobulins play a key role in the body’s immune system. They are proteins produced by specific immune cells called plasma cells in response to bacteria, viruses, and other microorganisms as well as exposures to other substances that are recognised by the body as “non-self” harmful antigens. This test measures the amount of immunoglobulins A, G, and M (IgA, IgG, IgM) in the blood and, in certain circumstances, in cerebrospinal fluid (CSF) or saliva. The first time a person is infected or otherwise exposed to a foreign substance (antigen), their immune system recognises the microorganism or substance as “non-self” and stimulates B-cells (a type of lymphocyte or white blood cell) to produce specific immunoglobulin(s), also called antibodies, that can bind to and neutralise the threat. With subsequent exposures, the immune system “remembers” the antigen that was encountered, which allows for the rapid production of more antibodies by plasma cells (long lived subset of B-cells that are like antibody factories in the bone marrow) and, in the case of microorganisms, helps prevent re-infection. There are five classes of immunoglobulins and several subclasses. Each class represents a group of antibodies and has a slightly different role. Classes of immunoglobulins include:Immunoglobulin M (IgM) – IgM antibodies are produced as a body’s first response to a new infection or to a new “non-self” antigen, providing short-term protection. They increase for several weeks and then decline as IgG production begins. Immunoglobulin G (IgG) – About 70-80% of the immunoglobulins in the blood are IgG. Specific IgG antibodies are produced during an initial infection or other antigen exposure, rising a few weeks after it begins, then decreasing and stabilising. The body retains a catalogue of IgG antibodies that can be rapidly reproduced whenever exposed to the same antigen. IgG antibodies form the basis of long-term protection against microorganisms. In those with a normal immune system, sufficient IgG is produced to prevent re-infection. Vaccinations use this process to prevent infections adding to the catalogue of IgG antibodies, by exposing a person to a killed or weakened, live microorganism or to an antigen that stimulates recognition of the microorganism. IgG is the only immunoglobulin that can pass through the placenta from the mother to the baby. The mother’s IgG antibodies provide protection to the developing baby during pregnancy and then during its first few months of life after birth. There are four subclasses of IgG: IgG1, IgG2, IgG3, and IgG4. Immunoglobulin A (IgA) – IgA comprises about 15% of the total lung and stomach secretions, and breast milk. IgA provides protection against infection in mucosal areas of the body such as the respiratory tract (sinus and lungs) and the gastrointestinal tract (stomach and intestines). When passed from mother to baby during breast-feeding, it helps protect the infant’s gastrointestinal tract. Significant amounts of IgA are not produced by a baby until after 6 months of age so any IgA present in a baby’s blood before then is from the mother’s milk. There are two IgA subclasses: IgA1 and IgA2. Immunoglobulin D (IgD) – This is not usually a secreted antibody, it is the first antibody produced as a receptor on B-cells (B-lymphocytes), it can be abnormally secreted in rare disorders (Hyper IgD Syndrome or HIDS). Immunoglobulin E (IgE) – IgE is associated with allergies, allergic diseases, and with parasitic infections. It is almost always measured as part of an allergy testing blood panel but typically is not included as part of a quantitative immunoglobulins test because the levels are far too low to be detected by the same methods. Quantitative immunoglobulins testing measures the total amount of each primary immunoglobulin class, IgA, IgM, and IgG, without distinguishing between subclasses. Separate testing can be performed to measure immunoglobulin subclasses and/or to detect and measure specific antibodies. A variety of conditions can cause an increase (hypergammaglobulinemia) or decrease (hypogammaglobulinemia) in the production of immunoglobulins. Some cause an excess or deficiency of all classes of immunoglobulins while others affect only one class. Some of the conditions are passed from one generation to the next (inherited) and others are acquired. How is the sample collected for testing?A blood sample is obtained by inserting a needle into a vein in the arm. When required, a sample of cerebrospinal fluid (CSF) is collected by a healthcare professional from the lower back using a procedure called a lumbar puncture or spinal tap. Saliva or other fluids are collected in a container provided by the laboratory. Is any test preparation needed to ensure the quality of the sample?No test preparation is needed. See MoreSee Less

Preparation for the Test

None

Sample Requirements

A blood sample drawn from a vein in your arm; sometimes a cerebrospinal fluid (CSF) or saliva sample

Additional Notes

Sometimes an IgM test is used to determine whether a newborn acquired an infection before or after birth (congenital). IgM may be produced by a baby, just like an adult, in response to infection. Due to the size of IgM antibodies, they cannot pass through the placenta from mother to baby during pregnancy. Thus, any IgM antibodies present in a newborn’s blood are not from the mother but were produced by the baby. Usually looking at both the babies and the mother’s blood tests for IgG and IgM antibodies allows doctors a better idea of when infection occurred.Infants with otherwise normal immune systems may have temporarily decreased IgG levels when production is delayed. Protection from infections is lost as concentrations of the mother’s IgG in the baby’s blood decrease over several months. The level of IgG remains at low concentrations until the baby’s IgM and IgG production ramps up. This creates a period of time during which the baby is at an increased risk for recurrent infections.Infants who are breastfed acquire IgA from breast milk. The IgA in breast milk can be protective against infections, particularly in the time between the decrease of mother’s antibodies and the production of the baby’s own antibodies.Those with conditions that cause decreased immunoglobulin levels often do not have a strong immune response to vaccinations; they may not produce a sufficient level of antibody to ensure protection and may not be able to receive live vaccines, such as those for polio or measles.Many laboratory tests measure antibodies in the blood. Those with immunoglobulin deficiencies may have false-negative results on these types of tests. For example, one test for coeliac disease detects the IgA class of anti-tissue transglutaminase antibody (anti-tTG). If a person has a deficiency in IgA, then results of this test may be negative when the person, in fact, has coeliac disease. If this is suspected to be the case, then a quantitative test for IgA may be performed.If IgG concentrations are decreased, or a deficiency in a subclass is suspected, then testing may be performed to detect and further define the deficiency. Subclass deficiencies can be present even when an immunoglobulin class concentration, such as IgG, is normal. These are usually subtle abnormalities, and as such they are rarely the cause of major clinical infection and subclass testing is now rarely performed.Some people with IgA deficiencies may develop anti-IgA antibodies. When those with anti-IgA are given blood component transfusions that contain IgA (such as plasma or immunoglobulin treatments), they may rarely experience a severe anaphylactic transfusion reaction. The current advice is only to test IgA deficient patients for IgA antibodies if they have previously reacted to a blood product. The majority of patients do not develop IgA antibodies and even in those with an anti-IgA antibody most do not react to blood products.